Related Experiment Videos
[The ovarian hyperstimulation syndrome. Institutional experience]
C Serviere Zaragoza1, A Camarero García, S Carranza Lira
1Unidad de Reproducción Asistida, Instituto Nacional de Perinatología, SS, México, D.F.
Ginecologia Y Obstetricia De Mexico
|October 1, 1994
Summary
This study on Ovarian Hyperstimulation Syndrome (OHS) found menotropins increased syndrome frequency. Due to unknown causes, treatment focuses on maintenance, making prevention the best strategy.
Area of Science:
- Reproductive endocrinology
- Gynecology
Background:
- Ovarian Hyperstimulation Syndrome (OHS) is a serious complication of ovulation induction.
- Etiology of OHS remains largely unknown, complicating treatment strategies.
Purpose of the Study:
- To analyze clinical characteristics and outcomes of hospitalized patients with OHS.
- To identify potential risk factors and contributing agents for OHS development.
Main Methods:
- Retrospective analysis of 30 hospitalized patients diagnosed with OHS.
- Evaluation of factors including menotropin use, pregnancy outcomes, and syndrome presentation.
Main Results:
- Menotropin administration was associated with a higher incidence of OHS.
- Multiple pregnancies occurred in 33% of cases, with an abortion rate of 16%.
Conclusions:
- Current OHS treatment is primarily supportive due to unknown etiology.
- Preventive measures are crucial for managing OHS risk in patients undergoing ovulation induction.